Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

G20 Meets Fresh Wave Of COVID With ‘Be Prepared’ Motto, Digital Focus

Tackling AMR A Priority

Executive Summary

As the COVID-19 graph trends upward in countries like India, preparing for future pandemics is high on the agenda of intergovernmental forum G20. Digital healthcare and governance tools, One Health approach and tackling AMR emerged as focus areas at the recent meeting of its Health Working Group

You may also be interested in...



J&J CEO On Stereotypes, Innovation Secret Sauce And Kenvue

J&J chairman and CEO Joaquin Duato shares striking glimpses of his own life journey at a recent summit as he underscores the value of diversity, equity and inclusion. He also discusses the company’s formulae for innovation and the Kenvue spin out.

Global CEO Grouping Lays Out Japan, Wider Priorities Ahead Of G7 Meeting

The Biopharmaceutical CEO Roundtable has added a chorus of C-suite voices to ongoing calls for Japan reform discussions, while also flagging key global health agenda items for the upcoming G7 meeting in the country.

Japan Lays Out New Antibiotics Plan As It Addresses Resistance Issues

A new five-year strategic plan to counter antimicrobial resistance includes concrete new goals to reduce rates of resistance to specific drugs and support the development of new products.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC148250

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel